Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-A meta-analysis

被引:77
作者
Zhang, Yun-Bo [1 ]
Chen, Wen-Hua
Guo, Jing-Jing [1 ]
Fu, Zheng-Hai [1 ]
Yi, Cheng [1 ]
Zhang, Ming [1 ]
Na, Xiao-Lin [1 ]
机构
[1] Harbin Med Univ, Coll Publ Hlth, Dept Environm Hyg, Harbin 150086, Heilongjiang Pr, Peoples R China
关键词
Isoflavone supplementation; Body weight; Blood glucose; Fasting insulin; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PHYTOESTROGEN GENISTEIN; PLASMA-LIPIDS; PROTEIN SUPPLEMENTATION; MENOPAUSAL WOMEN; CHINESE WOMEN; DISEASE RISK; MARKERS;
D O I
10.1016/j.nut.2012.03.019
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The objective of this study was to conduct a systematic review and a meta-analysis to confirm the effects of soy isoflavone supplementation on body weight, fasting glucose, and insulin level in non-Asian postmenopausal women. Methods: We searched the PubMed, EMBASE, and Cochrane databases up to October 2010 for randomized controlled trials regarding the effects of isoflavone supplementation on body weight, fasting glucose, and insulin level. Pooled estimates and 95% confidence intervals (CIs) were calculated by the fixed-and-random-effects model. Results: Nine studies with 528 participants for body weight, 11 studies with 1182 participants for fasting glucose, and 11 studies with 1142 participants for fasting insulin were included, respectively. Significant reductions were found in body weight [weighted mean difference (WMD), -0.515; 95% CI: -0.895 to -0.134; P = 0.008), glucose level (WMD, -0.189; 95%CI: -0.344 to -0.033), and fasting insulin level (WMD, -0.940; 95%CI: -1.721 to -0.159) with soy isoflavone supplementation compared with placebo control group in non-Asian postmenopausal women after adjusted by unpublished studies. Furthermore, isoflavone supplementation in shorter duration (<6 mo) could significantly reduce body weight (WMD, -0.506; 95%CI: -0.888 to -0.124; P = 0.009) and longer duration (>= 6 mo) could significantly reduce blood glucose in postmenopausal women (WMD, -0.270; 95%CI: -0.430 to -0.110; P = 0.001). Meanwhile, more reduction in body weight was observed in the lower dose subgroup (dose < 100 mg). Moreover, it is more effective to reduce body weight and fasting insulin level with soy isoflavone supplementation in normal weight (body mass index < 30) than obese (body mass index >= 30) women. Conclusions: This meta-analysis showed soy isoflavone supplementation could be beneficial for body weight reduction, glucose, and insulin control in plasma. Large and well-designed studies are recommended to confirm this conclusion. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 30 条
  • [11] POSTMENOPAUSAL CHANGES OF LIPID AND GLUCOSE-METABOLISM - A REVIEW OF THEIR MAIN ASPECTS
    GASPARD, UJ
    GOTTAL, JM
    VANDENBRULE, FA
    [J]. MATURITAS, 1995, 21 (03) : 171 - 178
  • [12] Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women
    Goodman-Gruen, D
    Kritz-Silverstein, D
    [J]. JOURNAL OF NUTRITION, 2001, 131 (04) : 1202 - 1206
  • [13] Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women:: interactions with genotype and equol production
    Hall, WL
    Vafeiadou, K
    Hallund, J
    Bugel, S
    Reimann, M
    Koebnick, C
    Zunft, HJF
    Ferrari, M
    Branca, F
    Dadd, T
    Talbot, D
    Powell, J
    Minihane, AM
    Cassidy, A
    Nilsson, M
    Dahlman-Wright, K
    Gustafsson, JÅ
    Williams, CM
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (03) : 592 - 600
  • [14] Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes
    Hemmingsen, Bianca
    Lund, Soren S.
    Wetterslev, Jorn
    Vaag, Allan
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (01) : 1 - 9
  • [15] Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: A double-blind, randomized, placebo-controlled trial
    Ho, Suzanne C.
    Chen, Yu-Ming
    Ho, Susan S. S.
    Woo, Jean L. F.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (05): : 905 - 912
  • [16] Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
    Jadad, AR
    Moore, RA
    Carroll, D
    Jenkinson, C
    Reynolds, DJM
    Gavaghan, DJ
    McQuay, HJ
    [J]. CONTROLLED CLINICAL TRIALS, 1996, 17 (01): : 1 - 12
  • [17] Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes
    Jayagopal, V
    Albertazzi, P
    Kilpatrick, ES
    Howarth, EM
    Jennings, PE
    Hepburn, DA
    Atkin, SL
    [J]. DIABETES CARE, 2002, 25 (10) : 1709 - 1714
  • [18] Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women
    Khaodhiar, Lalita
    Ricciotti, Hope A.
    Li, Linglin
    Pan, Weijun
    Sehickel, Mary
    Zhou, Jinrong
    Blackburn, George L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (01): : 125 - 132
  • [19] Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes
    Liu, Zhao-min
    Chen, Yu-ming
    Ho, Suzanne C.
    Ho, Yee Ping
    Woo, Jean
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (05) : 1394 - 1401
  • [20] Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation
    Puska, P
    Korpelainen, V
    Hoie, LH
    Skovlund, E
    Smerud, KT
    [J]. BRITISH JOURNAL OF NUTRITION, 2004, 91 (03) : 393 - 401